About CardiAMP Autologous Cell Therapy Granted FDA Breakthrough ... and ultimately treat microvascular dysfunction. The mechanisms that lead to microvascular dysfunction, including fibrotic ...

Autologous Tissue. A second approach to reconstruction ... They are more complex procedures, requiring microvascular anastomoses and carrying a higher risk of total flap loss.

The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021. Changes in vascular density in the ...